Usefulness of FDG-PET to diagnose intravascular lymphoma with encephalopathy and renal involvement

Acta Clinica Belgica

Volumn 63, Issue 3, 2008, Pages 185-189

  Balkema, C ^a   Meersseman, W ^a   Hermans, G ^a   Stroobants, S ^b   Verhoef, G ^a   Verbeken, E ^a   Demaerel, P ^a   Blockmans, D ^a  

^a Department of General Internal Medicine ^*  (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

FDG PET; FUO; Intravascular lymphoma

Indexed keywords

ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUORODEOXYGLUCOSE; LACTATE DEHYDROGENASE; METHOTREXATE; RITUXIMAB; STEROID; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG MEGADOSE; DRUG UPTAKE; ENZYME BLOOD LEVEL; FEMALE; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE UNIT; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY DISEASE; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SYMPTOM;

EID: 47949090938     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2008.029     Document Type: Article

References (19)

1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17 (12):3835-49.
2. Thomas DA , Cortes J, O'Brien S, et al. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukaemia. J Clin Oncol 1999; 17: 2461-70.
3. Ferreri AJM, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haem 2004; 127: 173-83.
4. Zuckerman D, Seliem R, Hochberg E . Intravascular lymphoma: The Oncologist's "Great imitator". The Oncologist 2006;11:496-502.
5. Nakahara T, Saito T, Muroi A, et al. Intravascular lymphomatosis presenting as an ascending cauda equinaxonus medullaris syndrome: remission after biweekly CHOP therapy. J Neurol Neurosurg Psychiatry 1999;67:403-6.
6. Calamia KT, Miller A, Shuster EA, et al. Intravascular lymphomatosis. A report of ten patients with central nervous system involvement and a review of the disease process. Adv Exp Med Biol 1999;455:249-65.
7. Vieren M, Sciot R, Robberecht W. Intravascular lymphomatosis of the brain: a diagnostic problem. Clin Neurol Neurosurg 1999; 101:33-6.
8. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis. A systemic disease with neurologic manifestations, Cancer 1993;71:3156-64.
9. Devlin T, Moll S, Hulette C, Morgenlander JC. Intravascular malignant lymphomatosis with neurologic presentation: factors facilitating antemortem diagnosis. South Med J 1998; 91: 672-6.
10. Baehring JM, Longtine J, Hochberg FH. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 2003; 61: 237-48.
11. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101(10): 3875-6.
12. Hoshino A, Kawada A, Ukita T, et al. Usefulness of FDG-PET to diagnose intravascular lymhomatosis presenting as fever of unknown origin. Am J Hematol 2004; 76:236-9.
13. Kusaba T, Hatta T, Tanda S, et al. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab. Clin Nephrol 2006; 3:222-6.
14. Spaepen K, Stroobants S, Dupont P, et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with agressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13(9): 1356-63.
15. Guyomard S, Salles G, Coudurier M, et al. Prevalence and pattern of antinuclear auto-antibodies in 347 patients with non-Hodgkin's lymphoma. Br J Haem 2003; 123: 90-9.
16. Koizumi M, Nishimura M, Yokota A, et al. Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone marrow transplant 2001; 27(10):1101-3.
17. Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004;15(8):1215-21.
18. Yamaguchi M, Kimura M, Watanabe Y, et al. Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis. Bone marrow transplant 2001; 27(1):89-91.
19. Rose C, Satumont D, Jouet JP. Successful autologous bone marrow transplantation in intravascular lymphomatosis. Br J Haematol 1999;. 105(1):313-4.